vs
INTERPARFUMS INC（IPAR）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
INTERPARFUMS INCの直近四半期売上が大きい（$386.2M vs $303.4M、Sotera Health Coの約1.3倍）。Sotera Health Coの純利益率が高く（11.5% vs 7.3%、差は4.2%）。INTERPARFUMS INCの前年同期比売上増加率が高い（6.8% vs 4.6%）。INTERPARFUMS INCの直近四半期フリーキャッシュフローが多い（$145.0M vs $52.4M）。過去8四半期でSotera Health Coの売上複合成長率が高い（10.6% vs 9.2%）
インターパフューム社はグローバルな高級フレグランス企業で、有名ラグジュアリーファッション・ライフスタイルブランドと提携し、香水、ボディケア、関連化粧品の開発・製造・販売を行っています。世界の主要市場で、百貨店、美容専門店、公式ECサイトを通じて消費者に商品を提供しています。
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
IPAR vs SHC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $386.2M | $303.4M |
| 純利益 | $28.1M | $34.8M |
| 粗利率 | 61.5% | 54.7% |
| 営業利益率 | 7.1% | 23.2% |
| 純利益率 | 7.3% | 11.5% |
| 売上前年比 | 6.8% | 4.6% |
| 純利益前年比 | 16.0% | 182.8% |
| EPS（希薄化後） | $0.88 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $386.2M | $303.4M | ||
| Q3 25 | $429.6M | $311.3M | ||
| Q2 25 | $333.9M | $294.3M | ||
| Q1 25 | $338.8M | $254.5M | ||
| Q4 24 | $361.5M | $290.2M | ||
| Q3 24 | $424.6M | $285.5M | ||
| Q2 24 | $342.2M | $276.6M | ||
| Q1 24 | $324.0M | $248.2M |
| Q4 25 | $28.1M | $34.8M | ||
| Q3 25 | $65.8M | $48.4M | ||
| Q2 25 | $32.0M | $8.0M | ||
| Q1 25 | $42.5M | $-13.3M | ||
| Q4 24 | $24.2M | $12.3M | ||
| Q3 24 | $62.3M | $17.0M | ||
| Q2 24 | $36.8M | $8.8M | ||
| Q1 24 | $41.0M | $6.3M |
| Q4 25 | 61.5% | 54.7% | ||
| Q3 25 | 63.5% | 57.0% | ||
| Q2 25 | 66.2% | 56.6% | ||
| Q1 25 | 63.7% | 53.2% | ||
| Q4 24 | 64.5% | 56.6% | ||
| Q3 24 | 63.9% | 55.4% | ||
| Q2 24 | 64.5% | 55.2% | ||
| Q1 24 | 62.5% | 51.2% |
| Q4 25 | 7.1% | 23.2% | ||
| Q3 25 | 25.3% | 23.4% | ||
| Q2 25 | 17.7% | 6.4% | ||
| Q1 25 | 22.2% | -5.8% | ||
| Q4 24 | 10.0% | 30.0% | ||
| Q3 24 | 25.0% | 28.2% | ||
| Q2 24 | 18.9% | 27.8% | ||
| Q1 24 | 21.0% | 21.4% |
| Q4 25 | 7.3% | 11.5% | ||
| Q3 25 | 15.3% | 15.5% | ||
| Q2 25 | 9.6% | 2.7% | ||
| Q1 25 | 12.5% | -5.2% | ||
| Q4 24 | 6.7% | 4.2% | ||
| Q3 24 | 14.7% | 6.0% | ||
| Q2 24 | 10.8% | 3.2% | ||
| Q1 24 | 12.7% | 2.5% |
| Q4 25 | $0.88 | $0.12 | ||
| Q3 25 | $2.05 | $0.17 | ||
| Q2 25 | $0.99 | $0.03 | ||
| Q1 25 | $1.32 | $-0.05 | ||
| Q4 24 | $0.78 | $0.05 | ||
| Q3 24 | $1.93 | $0.06 | ||
| Q2 24 | $1.14 | $0.03 | ||
| Q1 24 | $1.27 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $137.1M | $344.6M |
| 総負債低いほど良い | $176.0M | $2.1B |
| 株主資本純資産 | $880.7M | $606.0M |
| 総資産 | $1.6B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.20× | 3.53× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $137.1M | $344.6M | ||
| Q3 25 | $77.5M | $299.2M | ||
| Q2 25 | $53.9M | $332.4M | ||
| Q1 25 | $75.3M | $304.4M | ||
| Q4 24 | $109.3M | $277.2M | ||
| Q3 24 | $78.8M | $306.7M | ||
| Q2 24 | $37.7M | $246.1M | ||
| Q1 24 | $76.1M | $261.1M |
| Q4 25 | $176.0M | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | $157.3M | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $880.7M | $606.0M | ||
| Q3 25 | $870.9M | $550.5M | ||
| Q2 25 | $839.4M | $511.3M | ||
| Q1 25 | $788.6M | $414.1M | ||
| Q4 24 | $744.9M | $404.9M | ||
| Q3 24 | $778.5M | $470.2M | ||
| Q2 24 | $717.1M | $422.8M | ||
| Q1 24 | $708.1M | $429.4M |
| Q4 25 | $1.6B | $3.3B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.6B | $3.2B | ||
| Q1 25 | $1.4B | $3.1B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.5B | $3.1B | ||
| Q2 24 | $1.4B | $3.1B | ||
| Q1 24 | $1.3B | $3.1B |
| Q4 25 | 0.20× | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | — | 5.36× | ||
| Q4 24 | 0.21× | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | — | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $146.5M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $145.0M | $52.4M |
| FCFマージンFCF / 売上 | 37.5% | 17.3% |
| 設備投資強度設備投資 / 売上 | 0.4% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 5.21× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $190.5M | $149.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $146.5M | $103.1M | ||
| Q3 25 | $63.9M | $71.2M | ||
| Q2 25 | $11.9M | $57.4M | ||
| Q1 25 | $-7.4M | $55.5M | ||
| Q4 24 | $138.0M | $55.7M | ||
| Q3 24 | $76.1M | $97.5M | ||
| Q2 24 | $25.5M | $61.3M | ||
| Q1 24 | $-52.0M | $9.7M |
| Q4 25 | $145.0M | $52.4M | ||
| Q3 25 | $57.6M | $35.0M | ||
| Q2 25 | $-3.3M | $26.2M | ||
| Q1 25 | $-8.8M | $35.6M | ||
| Q4 24 | $136.1M | $-10.2M | ||
| Q3 24 | $75.4M | $61.1M | ||
| Q2 24 | $24.4M | $19.4M | ||
| Q1 24 | $-53.0M | $-25.2M |
| Q4 25 | 37.5% | 17.3% | ||
| Q3 25 | 13.4% | 11.2% | ||
| Q2 25 | -1.0% | 8.9% | ||
| Q1 25 | -2.6% | 14.0% | ||
| Q4 24 | 37.7% | -3.5% | ||
| Q3 24 | 17.8% | 21.4% | ||
| Q2 24 | 7.1% | 7.0% | ||
| Q1 24 | -16.4% | -10.2% |
| Q4 25 | 0.4% | 16.7% | ||
| Q3 25 | 1.5% | 11.6% | ||
| Q2 25 | 4.5% | 10.6% | ||
| Q1 25 | 0.4% | 7.8% | ||
| Q4 24 | 0.5% | 22.7% | ||
| Q3 24 | 0.2% | 12.7% | ||
| Q2 24 | 0.3% | 15.2% | ||
| Q1 24 | 0.3% | 14.1% |
| Q4 25 | 5.21× | 2.96× | ||
| Q3 25 | 0.97× | 1.47× | ||
| Q2 25 | 0.37× | 7.21× | ||
| Q1 25 | -0.17× | — | ||
| Q4 24 | 5.69× | 4.52× | ||
| Q3 24 | 1.22× | 5.73× | ||
| Q2 24 | 0.69× | 7.00× | ||
| Q1 24 | -1.27× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IPAR
| European Based Operations | $232.7M | 60% |
| United States Based Operations | $155.2M | 40% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
